[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Feinstein, 1978 - Google Patents

Acquired inhibitors of factor V

Feinstein, 1978

Document ID
15882036484064953075
Author
Feinstein D
Publication year
Publication venue
Thrombosis and Haemostasis

External Links

Snippet

The clinical and laboratory data on the 12 patients with an acquired inhibitor to factor V have been reviewed. The degree of clinical bleeding in these patients varied from none to severe, and in most patients the inhibitor was transient. The combination of a markedly prolonged …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Similar Documents

Publication Publication Date Title
Feinstein Acquired inhibitors of factor V
Teitel et al. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
Lechner Acquired inhibitors in nonhemophilic patients
Ratnoff et al. The activation of Christmas factor (factor IX) by activated plasma thromboplastin antecedent (activated factor XI)
Yin et al. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus
Glueck et al. A circulating anticoagulant in gamma-1A-multiple myeloma: its modification by penicillin.
Feinstein et al. Factor V anticoagulants: clinical, biochemical, and immunological observations
Niemetz et al. Activated coagulation factors: in‐vivo and in‐vitro studies
Deitcher et al. Acquired free protein S deficiency associated with multiple myeloma: a case report
Niléhn et al. Plasma Prothrombin during Treatment with Dicumarol: I. Immunochemical Determination of its Concentration in Plasma
Frances et al. Cutaneous necrosis associated with the lupus anticoagulant
Frommeyer Jr et al. Refractoriness in hemophilia to coagulation-promoting agents: whole blood and plasma derivatives
Rivard et al. Cofactor of the “lupus anticoagulant”
Stefanini Activity of plasma labile factor in disease
Schreiber et al. Hageman factor-independent fibrinolytic pathway
LANE et al. Factor V antibody and disseminated intravascular coagulation
Pascuzzi et al. Thromboplastin generation accelerator, a newly recognized component of the blood coagulation mechanism present in excess in certain thrombotic states
Zucker et al. IgM Inhibitors of the Contact Activation Phase of Coagulation in Chlorpromazine‐Treated Patients
Spaet et al. Inactivation of thromboplastin in human blood
Stenbjerg et al. A circulating factor V inhibitor: possible side effect of treatment with streptomycin
Stewart et al. vWf inhibitor detection by competitive ELISA
Criel et al. A case of IgM antibodies which inhibit the contact activation of blood coagulation
Crowell Jr Observations on a factor‐V inhibitor
Lechner Factor IX-inhibitors
Connor et al. A labile serum factor clotting defect: its demonstration by the thromboplastin generation test and its clinical significance